Homeostatic chemokine receptors and organ-specific metastasis

Nature Reviews Immunology

Volumn 11, Issue 9, 2011, Pages 597-606

  Zlotnik, Albert ^a   Burkhardt, Amanda M ^a   Homey, Bernhard ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; PLERIXAFOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CANCER CELL; HUMAN; IMMUNE EVASION; LEUKEMIA; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; LYMPHOMA; METASTASIS; NONHUMAN; ORGANOGENESIS; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANTINEOPLASTIC AGENTS; CHEMOKINES; HOMEOSTASIS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; ORGANOGENESIS; RECEPTORS, CHEMOKINE;

EID: 80052094283     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3049     Document Type: Review

References (124)

1. Zlotnik, A., Yoshie, O. & Nomiyama, H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 7, 243 (2006).
2. Soria, G. et al. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. Cytokine 44, 191-200 (2008).
3. Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222-225 (2011).
4. Gerber, P. A., Hippe, A., Buhren, B. A., Muller, A. & Homey, B. Chemokines in tumor-associated angiogenesis. Biol. Chem. 390, 1213-1223 (2009).
5. Fan, L., Reilly, C. R., Luo, Y., Dorf, M. E. & Lo, D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164, 3955-3959 (2000). (Pubitemid 30215047)
6. Muller, G., Reiterer, P., Hopken, U. E., Golfier, S. & Lipp, M. Role of homeostatic chemokine and sphingosine-1-phosphate receptors in the organization of lymphoid tissue. Ann. NY Acad. Sci. 987, 107-116 (2003). (Pubitemid 36584012)
7. Kabashima, K. et al. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171, 1249-1257 (2007). (Pubitemid 47582898)
8. Jang, M. H. et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176, 803-810 (2006). (Pubitemid 43099676)
9. Britschgi, M. R., Link, A., Lissandrin, T. K. & Luther, S. A. Dynamic modulation of CCR7 expression and function on naive T lymphocytes in vivo. J. Immunol. 181, 7681-7688 (2008).
10. Hardtke, S., Ohl, L. & Forster, R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 106, 1924-1931 (2005). (Pubitemid 41291702)
11. Lopez-Giral, S. et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J. Leukoc. Biol. 76, 462-471 (2004). (Pubitemid 39006961)
12. Ohl, L. et al. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J. Exp. Med. 197, 1199-1204 (2003). (Pubitemid 36570075)
13. Chen, S. C. et al. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168, 1001-1008 (2002).
14. Luther, S. A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J. G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471-481 (2000).
15. Schaerli, P. et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192, 1553-1562 (2000).
16. Scimone, M. L. et al. CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes. J. Exp. Med. 199, 1113-1120 (2004). (Pubitemid 38619907)
17. Wengner, A. M. et al. CXCR5-and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum. 56, 3271-3283 (2007). (Pubitemid 47585423)
18. Gossens, K. et al. Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25. J. Exp. Med. 206, 761-778 (2009).
19. Vicari, A. P. et al. TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7, 291-301 (1997). (Pubitemid 27392020)
20. Johansson-Lindbom, B. & Agace, W. W. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Rev. 215, 226-242 (2007). (Pubitemid 46212243)
21. Walters, M. J. et al. Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 335, 61-69 (2010).
22. Homey, B. et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nature Med. 8, 157-165 (2002). (Pubitemid 34155127)
23. Morteau, O. et al. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J. Immunol. 181, 6309-6315 (2008).
24. Doitsidou, M. et al. Guidance of primordial germ cell migration by the chemokine SDF-1. Cell 111, 647-659 (2002). (Pubitemid 35441247)
25. Knaut, H., Werz, C., Geisler, R. & Nusslein-Volhard, C. A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor. Nature 421, 279-282 (2003). (Pubitemid 36139133)
26. Cui, K. et al. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. J. Surg. Res. 26 Mar 2010 (doi:10.1016/j.jss.2010.03.001).
27. Steinberg, M. & Silva, M. Plerixafor: a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma. Clin. Ther. 32, 821-843 (2010).
28. Mahabaleshwar, H., Boldajipour, B. & Raz, E. Killing the messenger: the role of CXCR7 in regulating primordial germ cell migration. Cell Adh. Migr. 2, 69-70 (2008).
29. Valentin, G., Haas, P. & Gilmour, D. The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr. Biol. 17, 1026-1031 (2007). (Pubitemid 46899533)
30. Ehtesham, M., Mapara, K. Y., Stevenson, C. B. & Thompson, R. C. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett. 274, 305-312 (2009).
31. Raz, E. & Mahabaleshwar, H. Chemokine signaling in embryonic cell migration: a fisheye view. Development 136, 1223-1229 (2009).
32. Thelen, M. & Thelen, S. CXCR7, CXCR4 and CXCL12: an eccentric trio? J. Neuroimmunol. 198, 9-13 (2008).
33. Dambly-Chaudiere, C., Cubedo, N. & Ghysen, A. Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev. Biol. 7, 23 (2007).
34. Liles, W. C. et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102, 2728-2730 (2003). (Pubitemid 37248839)
35. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. & Littman, D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599 (1998). (Pubitemid 28319251)
36. Minami, E., Laflamme, M. A., Saffitz, J. E. & Murry, C. E. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112, 2951-2958 (2005). (Pubitemid 41612297)
37. Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56 (2001). (Pubitemid 32225831)
38. Williams, S. A. et al. Multiple functions of CXCL12 in a syngeneic model of breast cancer. Mol. Cancer 9, 250 (2010).
39. Darash-Yahana, M. et al. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18, 1240-1242 (2004). (Pubitemid 39561563)
40. Arya, M. et al. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. J. Exp. Ther. Oncol. 4, 291-303 (2004). (Pubitemid 40189442)
41. Su, L. et al. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin. Cancer Res. 11, 8273-8280 (2005). (Pubitemid 41746937)
42. Phillips, R. J. et al. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 167, 1676-1686 (2003). (Pubitemid 36760683)
43. Speetjens, F. M. et al. Nuclear localization of CXCR4 determines prognosis for colorectal cancer patients. Cancer Microenviron. 2, 1-7 (2009).
44. Zhao, B. C. et al. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J. Gastroenterol. 17, 2389-2396 (2011).
45. Ying, J., Xu, Q., Zhang, G., Liu, B. & Zhu, L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med. Oncol. 1 Jun 2011 (doi:10.1007/s12032-011-9990-0).
46. Savarin-Vuaillat, C. & Ransohoff, R. M. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics 4, 590-601 (2007). (Pubitemid 47499286)
47. Terasaki, M. et al. CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target. Brain Tumor Pathol. 28, 89-97 (2011).
48. Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M. T. & Hwang, S. T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl Cancer Inst. 93, 1638-1643 (2001). (Pubitemid 33094871)
49. Murakami, T. et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62, 7328-7334 (2002). (Pubitemid 36025256)
50. Cunningham, H. D. et al. Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Transl. Oncol. 3, 354-361 (2010).
51. Schioppa, T. et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402 (2003). (Pubitemid 37392484)
52. Bachelder, R. E., Wendt, M. A. & Mercurio, A. M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62, 7203-7206 (2002). (Pubitemid 36025239)
53. Simonetti, O. et al. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur. J. Cancer 42, 1181-1187 (2006).
54. Homey, B. et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J. Immunol. 164, 3465-3470 (2000). (Pubitemid 30169794)
55. Hla, T. & Brinkmann, V. Sphingosine 1-phosphate (S1P): physiology and the effects of S1P receptor modulation. Neurology 76, S3-S8 (2011).
56. Bradaric, M. J. et al. Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors. J. Ovarian Res. 4, 4 (2011).
57. Amersi, F. F. et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin. Cancer Res. 14, 638-645 (2008). (Pubitemid 351231142)
58. Letsch, A. et al. Functional CCR9 expression is associated with small intestinal metastasis. J. Invest. Dermatol. 122, 685-690 (2004). (Pubitemid 38471337)
59. Villablanca, E. J. et al. Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nature Med. 16, 98-105 (2010).
60. Alfonso-Perez, M. et al. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia. J. Leukoc. Biol. 79, 1157-1165 (2006). (Pubitemid 44835549)
61. Liu, F. Y. et al. NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck. Oncol. Rep. 25, 383-391 (2011).
62. Emmett, M. S., Lanati, S., Dunn, D. B., Stone, O. A. & Bates, D. O. CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation 18, 172-182 (2011).
63. Buonamici, S. et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 459, 1000-1004 (2009).
64. Erreni, M. et al. Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur. J. Cancer 46, 3383-3392 (2010).
65. Ye, Q. H. et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nature Med. 9, 416-423 (2003).
66. Bohn, O. L. et al. Biomarker profile in breast carcinomas presenting with bone metastasis. Int. J. Clin. Exp. Pathol. 3, 139-146 (2009).
67. Fingleton, B. Molecular targets in metastasis: lessons from genomic approaches. Cancer Genomics Proteomics 4, 211-221 (2007).
68. Furusato, B., Mohamed, A., Uhlen, M. & Rhim, J. S. CXCR4 and cancer. Pathol. Int. 60, 497-505 (2010).
69. Kakarala, M. & Wicha, M. S. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J. Clin. Oncol. 26, 2813-2820 (2008).
70. Groner, B., Vafaizadeh, V., Brill, B. & Klemmt, P. Stem cells of the breast and cancer therapy. Womens Health 6, 205-219 (2010).
71. Gonzalez-Sarmiento, R. & Perez-Losada, J. Breast cancer, a stem cell disease. Curr. Stem Cell Res. Ther. 3, 55-65 (2008). (Pubitemid 352024868)
72. O'Hayre, M. et al. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis. PLoS ONE 5, e11716 (2010).
73. Appaiah, H. et al. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. Cancer Biol. Ther. 10, 600-614 (2010).
74. Rhodes, L. V. et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res. 71, 603-613 (2010).
75. Wendt, M. K. et al. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 25, 4986-4997 (2006).
76. Wendt, M. K., Cooper, A. N. & Dwinell, M. B. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 27, 1461-1471 (2008). (Pubitemid 351317456)
77. Yang, G. et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl Acad. Sci. USA 103, 16472-16477 (2006). (Pubitemid 44715220)
78. Wislez, M. et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic Kras. Cancer Res. 66, 4198-4207 (2006).
79. Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447-458 (2004). (Pubitemid 39469981)
80. Pivarcsi, A. et al. Tumor immune escape by the loss of homeostatic chemokine expression. Proc. Natl Acad. Sci. USA 104, 19055-19060 (2007).
81. Gao, J. Q. et al. NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy. Cancer Immunol. Immunother. 58, 291-299 (2009).
82. Tessema, M. et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene 29, 5159-5170 (2010).
83. Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M. & Swartz, M. A. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749-752 (2010).
84. Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 475, 226-230 (2011).
85. Kajiyama, H. et al. Involvement of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int. J. Cancer 122, 91-99 (2008). (Pubitemid 350209982)
86. Burger, J. A., Stewart, D. J., Wald, O. & Peled, A. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer. Expert Rev. Anticancer Ther. 11, 621-630 (2011).
87. Jiang, Y. P., Wu, X. H., Shi, B., Wu, W. X. & Yin, G. R. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol. Oncol. 103, 226-233 (2006). (Pubitemid 44374693)
88. Ebos, J. M. et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232-239 (2009).
89. Lu, X. & Kang, Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 16, 5928-5935 (2010).
90. Liu, H. et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. Biochem. Biophys. Res. Commun. 401, 509-515 (2010).
91. Ishikawa, T. et al. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol. Rep. 21, 707-712 (2009).
92. Holm, N. T., Abreo, F., Johnson, L. W., Li, B. D. & Chu, Q. D. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). Breast Cancer Res. Treat. 113, 293-299 (2009).
93. Muller, A. et al. Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int. J. Cancer 118, 2147-2157 (2006).
94. Uchida, D. et al. Vesnarinone downregulates CXCR4 expression via upregulation of Kruppel-like factor 2 in oral cancer cells. Mol. Cancer 8, 62 (2009).
95. Weaver, D. L. et al. Effect of occult metastases on survival in node-negative breast cancer. N. Engl. J. Med. 364, 412-421 (2011).
96. Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071 (2010).
97. van 't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
98. Liang, Z. et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 64, 4302-4308 (2004). (Pubitemid 38802437)
99. Li, Y. M. et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6, 459-469 (2004). (Pubitemid 39469982)
100. Milliken, D., Scotton, C., Raju, S., Balkwill, F. & Wilson, J. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin. Cancer Res. 8, 1108-1114 (2002). (Pubitemid 35177363)
101. Oda, Y. et al. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression. Cancer Sci. 98, 1020-1026 (2007). (Pubitemid 46865386)
102. Akashi, T. et al. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci. 99, 539-542 (2008). (Pubitemid 351228571)
103. Hirata, H. et al. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin. Cancer Res. 13, 5056-5062 (2007). (Pubitemid 47502070)
104. Liang, J. J. et al. High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 19, 2598-2604 (2010).
105. Marechal, R. et al. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br. J. Cancer 100, 1444-1451 (2009).
106. Marchesi, F. et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res. 64, 8420-8427 (2004). (Pubitemid 39491782)
107. Franco, R. et al. Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome. Cancer Biol. Ther. 9, 423-429 (2010).
108. Franco, R. et al. CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. Front. Biosci. (Elite Ed.) 2, 13-21 (2009).
109. Scala, S. et al. Human melanoma metastases express functional CXCR4. Clin. Cancer Res. 12, 2427-2433 (2006).
110. van den Oord, J. The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine. Nature Clin. Pract. Oncol. 5, 440-441 (2008).
111. Ding, Y. et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin. Cancer Res. 9, 3406-3412 (2003). (Pubitemid 37082736)
112. Kaifi, J. T. et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J. Natl Cancer Inst. 97, 1840-1847 (2005). (Pubitemid 43033904)
113. Koishi, K. et al. Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J. Gastroenterol. 12, 7585-7590 (2006). (Pubitemid 46040568)
114. Takanami, I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int. J. Cancer 105, 186-189 (2003). (Pubitemid 36505319)
115. Katayama, A., Ogino, T., Bandoh, N., Nonaka, S. & Harabuchi, Y. Expression of CXCR4 and its down-regulation by IFN-γ in head and neck squamous cell carcinoma. Clin. Cancer Res. 11, 2937-2946 (2005). (Pubitemid 40525196)
116. Eisenhardt, A. et al. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur. Urol. 47, 111-117 (2005). (Pubitemid 39575727)
117. Kim, J. et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann. Surg. 244, 113-120 (2006). (Pubitemid 44297455)
118. Gunther, K. et al. Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7. Int. J. Cancer 116, 726-733 (2005). (Pubitemid 41099704)
119. Oda, Y. et al. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod. Pathol. 19, 738-745 (2006).
120. Russell, H. V., Hicks, J., Okcu, M. F. & Nuchtern, J. G. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J. Pediatr. Surg. 39, 1506-1511 (2004). (Pubitemid 39349733)
121. Wu, S. et al. Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse. J. Pediatr. Hematol. Oncol. 28, 216-220 (2006). (Pubitemid 43791829)
122. Mashino, K. et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 62, 2937-2941 (2002). (Pubitemid 34525782)
123. Yasumoto, K. et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 66, 2181-2187 (2006).
124. Yang, J., Wang, S., Zhao, G. & Sun, B. Effect of chemokine receptors CCR7 on disseminated behavior of human T cell lymphoma: clinical and experimental study. J. Exp. Clin. Cancer Res. 30, 51 (2011).